We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Alembic Pharmaceuticals announced its consolidated financial results for the quarter ending June 30, 2019. The company’s net profit rose by 37 per cent in Q1FY20, amounting to Rs 124 cr from Rs 90 cr in the same period previous fiscal.